Hind.Bio Science

Market Cap: Micro Cap
Industry: Software Products
ISIN: INE597C01021
NSEID:
BSEID: 532041
View on BSE

INR

7.86

0.03 (0.38%)

BSENSE

Jun 03, 03:30 PM

BSE+NSE Vol: 1.75 k

{
  "main_header": {
    "sid": 395126,
    "name": "Hind.Bio Science",
    "stock_name": "Hind.Bio Science",
    "full_name": "Hindustan Bio Sciences Ltd",
    "name_url": "stocks-analysis/hindbio-science",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 0,
    "country_id": 34,
    "currency": "INR",
    "cmp": "7.86",
    "chg": 0.03,
    "chgp": "0.38%",
    "dir": 1,
    "prev_price": "7.83",
    "mcapval": "8.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 532041,
    "symbol": "",
    "ind_name": "Software Products",
    "ind_code": 4,
    "sector_id": 73,
    "indexname": "India SENSEX",
    "isin": "INE597C01021",
    "curr_date": "Jun 03, 03:30 PM",
    "curr_time": "01:26 AM",
    "last_traded_at": "Jun 03, 03:30 PM IST",
    "bse_nse_vol": "1.75 k",
    "exc_status": "Active",
    "traded_date": "Jun 03, 2026",
    "traded_date_str": "2026 06 03",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/hindbio-science-395126-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Are Hindustan Bio Sciences Ltd latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-hindustan-bio-sciences-ltd-latest-results-good-or-bad-4032376",
        "imagepath": "",
        "date": "2026-06-02 19:28:22",
        "description": "Hindustan Bio Sciences Ltd has reported concerning financial results for the quarter ended March 2026, reflecting significant operational challenges. The company recorded net sales of ₹0.00 crores, a complete decline from ₹0.38 crores in the previous quarter, indicating a 100% quarter-on-quarter drop. This pattern of alternating quarters with zero revenue raises serious concerns about the company's operational viability and market presence.\n\nIn terms of profitability, Hindustan Bio Sciences experienced a net loss of ₹0.12 crores in Q4 FY26, a stark contrast to the net profit of ₹0.08 crores reported in the prior quarter. The operating profit before depreciation, interest, and tax (PBDIT) also stood at negative ₹0.12 crores, highlighting the company's inability to cover basic operational expenses without revenue generation.\n\nThe company's return on equity (ROE) was reported at 8.60%, with the latest quarter ..."
      },
      {
        "title": "Hindustan Bio Sciences Q4 FY26: Revenue Collapse Signals Deepening Operational Crisis",
        "link": "https://www.marketsmojo.com/news/result-analysis/hindustan-bio-sciences-q4-fy26-revenue-collapse-signals-deepening-operational-crisis-4028761",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/HindustanBioSci_quaterlyResult_4028761.png",
        "date": "2026-06-01 15:05:42",
        "description": "Hindustan Bio Sciences Ltd. reported a complete revenue collapse in Q4 FY26, with net sales plummeting to zero from ₹0.38 crores in the previous quarter, whilst simultaneously posting a net loss of ₹0.12 crores. The micro-cap pharmaceutical company, valued at just ₹8.32 crores, saw its shares decline 4.47% to ₹8.12 following the dismal quarterly performance, extending its one-year loss to 17.23%."
      },
      {
        "title": "Are Hindustan Bio Sciences Ltd latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-hindustan-bio-sciences-ltd-latest-results-good-or-bad-4023816",
        "imagepath": "",
        "date": "2026-05-30 19:45:11",
        "description": "Hindustan Bio Sciences Ltd's latest financial results for Q3 FY26 indicate a complex operational landscape characterized by significant revenue volatility and structural challenges. The company reported net sales of ₹0.38 crores, a recovery from zero sales in the previous quarter, which underscores the erratic nature of its revenue generation. This pattern raises concerns about the sustainability of its business model, especially given the company's five-year sales growth rate of -16.00%.\n\nThe net profit for the quarter was ₹0.08 crores, marking a recovery from a loss of ₹0.06 crores in the prior quarter. This profit recovery, while positive, is set against a backdrop of historical inconsistency, as the average return on equity (ROE) over recent years stands at 0.0%. The latest quarter's ROE of 14.00% reflects better capital efficiency when the company is operational, but this is not indicative of a stable ..."
      },
      {
        "title": "When is the next results date for Hindustan Bio Sciences Ltd?",
        "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-hindustan-bio-sciences-ltd-4001676",
        "imagepath": "",
        "date": "2026-05-20 23:18:16",
        "description": "The next results date for Hindustan Bio Sciences Ltd is scheduled for 30 May 2026...."
      },
      {
        "title": "Hindustan Bio Sciences Gains 5.18%: 2 Key Factors Driving the Week",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/hindustan-bio-sciences-gains-518-2-key-factors-driving-the-week-3943157",
        "imagepath": "",
        "date": "2026-04-11 17:10:56",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>6 Apr:</strong> Week opens at Rs.8.50</p>\n                    <p><strong>7 Apr:</strong> Golden Cross formation signals potential bullish breakout</p>\n                    <p><strong>8 Apr:</strong> Mojo Score upgraded to Sell from Strong Sell</p>\n                    <p><strong>10 Apr:</strong> Week closes at Rs.8.94 (+5.18%)</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.8.50</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.8.94</div><div class=\"stat-change positive\">+5.18%</div></..."
      },
      {
        "title": "Hindustan Bio Sciences Ltd Upgraded to Sell Amid Mixed Technical and Fundamental Signals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/hindustan-bio-sciences-ltd-upgraded-to-sell-amid-mixed-technical-and-fundamental-signals-3936559",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/HindustanBioSci_mojoScore_3936559.png",
        "date": "2026-04-08 08:10:15",
        "description": "Hindustan Bio Sciences Ltd, a micro-cap player in the Software Products sector, has seen its investment rating upgraded from Strong Sell to Sell as of 7 April 2026. This change is primarily driven by a shift in technical indicators signalling a mildly bullish trend, despite persistent weaknesses in the company’s financial fundamentals and valuation metrics."
      },
      {
        "title": "Golden Cross Forms in Hindustan Bio Sciences Ltd — On a Day the Stock Fell 4.9%. What the Mixed Signals Mean",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/hindustan-bio-sciences-ltd-forms-golden-cross-indicating-potential-bullish-breakout-3936132",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/HindustanBioSci_goldencross_3936132.png",
        "date": "2026-04-07 18:00:12",
        "description": "The 50-day moving average has crossed above the 200-day moving average for Hindustan Bio Sciences Ltd, signalling a golden cross on 7 Apr 2026. Yet, the stock declined 4.94% on the same day, while monthly momentum indicators remain bearish. This divergence between the moving averages and price action calls for a detailed examination of the signal's reliability."
      }
    ],
    "total": 106,
    "sid": "395126",
    "stock_news_url": "https://www.marketsmojo.com/news/hindustan-bio-sciences-395126"
  },
  "announcements": [
    {
      "caption": "Board Meeting Outcome for Approved Audited Results For The Fourth Quarter And Financial Year Ended 2026",
      "datetime": "30-May-2026",
      "details": "Financial Results for the Fourth Quarter and Financial Year ended 31st March 2026",
      "source": "BSE"
    },
    {
      "caption": "Audited Financial Results For The Fourth Quarter And Financial Year Ended 31St March 2026",
      "datetime": "30-May-2026",
      "details": "Audited Financial Results for the Fourth Quarter and Financial year ended 31st March 2026",
      "source": "BSE"
    },
    {
      "caption": "Appointment Of Internal Auditor For The Year 2026-27",
      "datetime": "30-May-2026",
      "details": "Appointment of Internal Auditor for the year 2026-27",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Are Hindustan Bio Sciences Ltd latest results good or bad?

2026-06-02 19:28:22

Hindustan Bio Sciences Ltd has reported concerning financial results for the quarter ended March 2026, reflecting significant operational challenges. The company recorded net sales of ₹0.00 crores, a complete decline from ₹0.38 crores in the previous quarter, indicating a 100% quarter-on-quarter drop. This pattern of alternating quarters with zero revenue raises serious concerns about the company's operational viability and market presence. In terms of profitability, Hindustan Bio Sciences experienced a net loss of ₹0.12 crores in Q4 FY26, a stark contrast to the net profit of ₹0.08 crores reported in the prior quarter. The operating profit before depreciation, interest, and tax (PBDIT) also stood at negative ₹0.12 crores, highlighting the company's inability to cover basic operational expenses without revenue generation. The company's return on equity (ROE) was reported at 8.60%, with the latest quarter ...

Read full news article

Hindustan Bio Sciences Q4 FY26: Revenue Collapse Signals Deepening Operational Crisis

2026-06-01 15:05:42

Hindustan Bio Sciences Ltd. reported a complete revenue collapse in Q4 FY26, with net sales plummeting to zero from ₹0.38 crores in the previous quarter, whilst simultaneously posting a net loss of ₹0.12 crores. The micro-cap pharmaceutical company, valued at just ₹8.32 crores, saw its shares decline 4.47% to ₹8.12 following the dismal quarterly performance, extending its one-year loss to 17.23%.

Read full news article

Are Hindustan Bio Sciences Ltd latest results good or bad?

2026-05-30 19:45:11

Hindustan Bio Sciences Ltd's latest financial results for Q3 FY26 indicate a complex operational landscape characterized by significant revenue volatility and structural challenges. The company reported net sales of ₹0.38 crores, a recovery from zero sales in the previous quarter, which underscores the erratic nature of its revenue generation. This pattern raises concerns about the sustainability of its business model, especially given the company's five-year sales growth rate of -16.00%. The net profit for the quarter was ₹0.08 crores, marking a recovery from a loss of ₹0.06 crores in the prior quarter. This profit recovery, while positive, is set against a backdrop of historical inconsistency, as the average return on equity (ROE) over recent years stands at 0.0%. The latest quarter's ROE of 14.00% reflects better capital efficiency when the company is operational, but this is not indicative of a stable ...

Read full news article

When is the next results date for Hindustan Bio Sciences Ltd?

2026-05-20 23:18:16

The next results date for Hindustan Bio Sciences Ltd is scheduled for 30 May 2026....

Read full news article

Hindustan Bio Sciences Gains 5.18%: 2 Key Factors Driving the Week

2026-04-11 17:10:56

Key Events This Week

6 Apr: Week opens at Rs.8.50

7 Apr: Golden Cross formation signals potential bullish breakout

8 Apr: Mojo Score upgraded to Sell from Strong Sell

10 Apr: Week closes at Rs.8.94 (+5.18%)

Read full news article

Hindustan Bio Sciences Ltd Upgraded to Sell Amid Mixed Technical and Fundamental Signals

2026-04-08 08:10:15

Hindustan Bio Sciences Ltd, a micro-cap player in the Software Products sector, has seen its investment rating upgraded from Strong Sell to Sell as of 7 April 2026. This change is primarily driven by a shift in technical indicators signalling a mildly bullish trend, despite persistent weaknesses in the company’s financial fundamentals and valuation metrics.

Read full news article

Golden Cross Forms in Hindustan Bio Sciences Ltd — On a Day the Stock Fell 4.9%. What the Mixed Signals Mean

2026-04-07 18:00:12

The 50-day moving average has crossed above the 200-day moving average for Hindustan Bio Sciences Ltd, signalling a golden cross on 7 Apr 2026. Yet, the stock declined 4.94% on the same day, while monthly momentum indicators remain bearish. This divergence between the moving averages and price action calls for a detailed examination of the signal's reliability.